サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1342071

乳房生検装置の世界市場：タイプ別、手技別、技術別、用途別、エンドユーザー別、地域別-2028年までの予測

Breast Biopsy Devices Market by Type, Procedure, Technique, Application, End User & Region - Global Forecast to 2028
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 260 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
乳房生検装置の世界市場：タイプ別、手技別、技術別、用途別、エンドユーザー別、地域別-2028年までの予測
出版日: 2023年08月08日
発行: MarketsandMarkets
ページ情報: 英文 260 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の乳房生検装置の市場規模は、2023年の16億米ドルから2028年には26億米ドルに達すると予測され、2023年から2028年までのCAGRは10.0%とみられています。

市場成長は、乳癌有病率の増加、乳癌検診プログラムの実施の増加、有利な償還設定、乳癌早期発見に対する意識の高まり、低侵襲・非侵襲手技に対する需要の高まりなど、さまざまな要因に後押しされています。これらの要因は市場拡大の主要促進要因であり、業界に大きなビジネスチャンスをもたらしています。

乳房生検機器市場は、タイプ別に生検針、ガイダンスシステム、生検台、 ローカリゼーションワイヤ、アッセイキット、液体生検機器、その他の機器に区分されます。生検針のサブセグメントが市場の主要シェアを占めています。このセグメントが市場を大きく支配している主な理由は、乳癌の発生が増加していることと、新興市場における乳癌診断率の上昇にあります。さらに、乳癌検診プログラムの確立や啓発キャンペーンといった政府の支援策が、乳房生検の採用をさらに促進すると予想されます。

乳房生検装置市場は、用途別に早期癌スクリーニング、治療法選択、治療モニタリング、再発モニタリングに大別されます。同分野の著しい成長は、有利な償還シナリオと高度なヘルスケアインフラの利用可能性に起因しています。過去数十年にわたる腫瘍組織の遺伝子解析に基づく精密医療と個別化癌治療の出現は、より特異的な治療選択肢をもたらし、予測期間中の同分野の成長にさらに影響を及ぼすと予想されます。

手技別では、乳房生検市場は針乳房生検、開腹手術乳房生検、液状乳房生検に大別されます。レビュー期間中にこのセグメントが大きく成長したのは、新製品の承認と発売によるものです。リキッド式乳房生検市場で事業を展開する企業は、資金提供や助成金を通じて臨床試験や研究に積極的に投資しており、これが市場のさらなる拡大に拍車をかけています。業界各社によるこうした取り組みは、リキッド乳房生検分野の成長を促進すると予想されます。

北米地域の乳房生検装置市場は、主に同地域の高いヘルスケア支出と対象疾患の有病率の上昇により、予測期間中に大きなシェアを占めると予想されます。さらに、技術の絶え間ない進歩、乳癌罹患率の増加、有利な償還条件、米国における新たな乳房密度通知法の施行が市場成長をさらに押し上げるとみられています。

当レポートでは、世界の乳房生検装置市場について調査し、タイプ別、手技別、技術別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
  • 規制状況
  • バリューチェーン分析
  • サプライチェーン分析
  • 生態系市場マップ
  • 技術分析
  • 貿易分析
  • 特許分析
  • ポーターのファイブフォース分析
  • 価格分析
  • ケーススタディ分析
  • 2023年～2025年の主要な会議とイベント
  • 主要な利害関係者と購入基準

第6章 乳房生検装置市場、タイプ別

  • イントロダクション
  • 生検針
  • ガイダンスシステム
  • 生検台
  • アッセイキット
  • 液体生検器具
  • ローカリゼーションワイヤ
  • その他

第7章 乳房生検装置市場、手技別

  • イントロダクション
  • 針乳房生検
  • 開腹外科的乳房生検
  • 液体乳房生検

第8章 乳房生検装置市場、技術別

  • イントロダクション
  • 画像誘導生検
  • 液体生検
  • その他

第9章 乳房生検装置市場、用途別

  • イントロダクション
  • 早期癌検診
  • 治療法選択
  • 治療モニタリング
  • 再発モニタリング

第10章 乳房生検装置市場、エンドユーザー別

  • イントロダクション
  • 病院と外科センター
  • ブレストケアセンター
  • 画像クリニックおよび診断センター

第11章 乳房生検装置市場、地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ

第12章 競合情勢

  • イントロダクション
  • 主要参入企業が採用した戦略
  • 収益シェア分析
  • 市場シェア分析
  • 主要企業の企業評価マトリックス（2022年）
  • スタートアップ/中小企業の企業評価マトリックス（2022年）
  • 競合ベンチマーキング
  • 企業フットプリント分析
  • 競合シナリオ

第13章 企業プロファイル

  • 主要参入企業
    • HOLOGIC, INC.
    • DANAHER CORPORATION
    • BECTON, DICKINSON AND COMPANY
    • QIAGEN
    • F. HOFFMANN-LA ROCHE LTD.
    • ARGON MEDICAL DEVICES
    • MERIT MEDICAL SYSTEMS
    • MENARINI SILICON BIOSYSTEMS SPA
    • GUARDANT HEALTH, INC.
    • NEOGENOMICS LABORATORIES, INC.
    • STERYLAB S.R.L
    • BIOCEPT, INC.
    • BIO-RAD LABORATORIES, INC.
    • EXACT SCIENCES CORPORATION
    • SYSMEX INOSTICS, INC.（A SUBSIDIARY OF SYSMEX CORPORATION）
  • その他の企業
    • THERMO FISHER SCIENTIFIC
    • CARDIFF ONCOLOGY INC.
    • MYRIAD GENETICS, INC.
    • ILLUMINA, INC.
    • FLUXION BIOSCIENCES, INC.
    • FUJIFILM HOLDINGS CORPORATION
    • INRAD, INC.
    • IZI MEDICAL PRODUCTS
    • REMINGTON MEDICAL INC.
    • CP MEDICAL

第14章 付録

目次
Product Code: MD 3615

The global breast biopsy devices market is projected to reach USD 2.6 billion by 2028 from USD 1.6 billion in 2023, at a CAGR of 10.0% from 2023 to 2028. The market growth is propelled by various factors, including the growing prevalence of breast cancer, the increasing implementation of breast cancer screening programs, favorable reimbursement settings, heightened awareness of early breast cancer detection, and rising demand for minimally invasive and non-invasive procedures. These factors are key drivers of market expansion, presenting significant business opportunities in the industry.

"The biopsy needles sub-segment to hold the largest share of the market in 2023."

Based on type, the breast biopsy devices market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and other devices. The biopsy needles sub-segment held a major share of the market. The advantages offered by the substantial market dominance of this segment can be primarily attributed to the increasing occurrence of breast cancer and the rising rate of breast cancer diagnosis in emerging markets. Moreover, supportive government initiatives, such as the establishment of breast cancer screening programs and awareness campaigns, are anticipated to drive the adoption of breast biopsy procedures further.

"The therapy selection application segment is projected to register the highest growth during the forecast period."

Based on application, the near breast biopsy market is broadly categorized into early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring. The significant growth of the segment is attributed to the favorable reimbursement scenario and availability of advanced healthcare infrastructure. The emergence of precision medicine and personalized cancer treatment based on genetic analysis of tumor tissue over the past few decades has resulted in more specific treatment options which is further expected to influence the growth of the segment during the forecast period.

"The liquid breast biopsy segment is projected to register the highest CAGR during the forecast period."

Based on procedure, the breast biopsy market is broadly categorized into needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy. The substantial growth of this segment during the review period can be attributed to the approvals and launches of new products. Companies operating in the liquid breast biopsy market are actively investing in clinical trials and research through funding and grants, which will fuel further market expansion. These initiatives by industry players are expected to drive the growth of the liquid breast biopsy segment.

"The market in the North America region is expected to witness the highest growth during the forecast period."

The breast biopsy market in the North America region is expected to hold a major share during the forecast period, primarily due to the high healthcare spending in the region and the rising prevalence of target diseases. Moreover, continuous advancements in technology, increasing incidence rates of breast cancer, favorable reimbursement conditions, and the implementation of new breast density notification laws in the US will further boost market growth.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%
  • By Designation: C-level-10%, Director-level-14%, and Others-76%
  • By Region: North America-40%, Europe-32%, Asia Pacific-20%, Latin America-5%, and the Middle East & Africa-3%

The prominent players in the breast biopsy devices market include Hologic Inc. (US), Danaher Corporation (US), Argon Medical Devices (US), Merit Medical Systems (US), Menarini-Silicon Biosystems (ITL), Becton Dickinson, and Company (US), Sterylab S.R.L ( Italy), Biocept, Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Guardant Health, Inc. (US), NeoGenomics (US), Sysmex Inostics (Germany), Qiagen (Germany), Exact Sciences Corporation (US).

Research Coverage

This report studies the breast biopsy market based on type, procedure, technique, application, end-user, and geography. This study analyses the breast biopsy market. Additionally, it discusses the elements that influence market expansion, examines the opportunities and difficulties that exist in the sector, and gives information on the market's competitive environment for market leaders. The research also examines the growth trends of micro-markets and projects the revenue of market segments for each of the five major regions (as well as the individual nations within each region).

Reasons to Buy the Report

The market leaders and new entrants will benefit from the report's information on the revenue figures that are most closely approximated for the entire breast biopsy market and its subsegments. This study will assist stakeholders in comprehending the competitive environment and gaining deeper insights to better position their companies and develop appropriate go-to-market strategies. In addition, the research provides details on the major market drivers, constraints, challenges, and opportunities, assisting stakeholders in understanding the industry's pulse.

This report provides insights on the following pointers:

  • Analysis of key drivers (increasing incidence of breast cancer, increasing number of breast cancer screening programs, increasing demand for minimally invasive and non-invasive procedures, growing awareness regarding early detection of breast cancer, improved reimbursement scenario), restraints (risk of infections associated with the use of biopsy needles, stringent regulatory approval procedures product recalls), opportunities (emerging economies offer high growth potential, the emergence of liquid biopsy and promising clinical trials, increasing public-private investments and funding) and challenges (underdeveloped healthcare infrastructure and dearth of resources in developing countries).
  • Product development/innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the breast biopsy market.
  • Market development: comprehensive information about lucrative markets-the report analyses the breast biopsy market across varied regions.
  • Market diversification: exhaustive information about new products, untapped geographies, recent developments, and investments in the breast biopsy market.
  • Competitive assessment: in-depth assessment of market shares, growth strategies, and service offerings of leading players like Hologic Inc. (US), Becton Dickinson, and Company (US), Danaher Corporation (US), Argon Medical Devices(US), Merit Medical Systems (US), Menarini-Silicon Biosystems (ITL), Guardant Health, Inc. (US), NeoGenomics (US), Sysmex Inostics (Germany), Sterylab S.R.L ( Italy), Qiagen (Germany), and Biocept, Inc. (US).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES
    • 1.5.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 GLOBAL BREAST BIOPSY DEVICES MARKET: RESEARCH METHODOLOGY STEPS
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 BREAST BIOPSY DEVICES MARKET: BREAKDOWN OF PRIMARIES
      • 2.1.2.1 Key data from primary sources
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.2.2 END-USER-BASED MARKET SIZE ESTIMATION
    • FIGURE 6 BREAST BIOPSY DEVICES MARKET: END-USER-BASED ESTIMATION
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH LIMITATIONS
  • 2.5 RISK ASSESSMENT
    • TABLE 1 BREAST BIOPSY DEVICES MARKET: RISK ASSESSMENT ANALYSIS
  • 2.6 BREAST BIOPSY DEVICES MARKET: RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 8 BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 9 BREAST BIOPSY DEVICES MARKET SHARE, BY PROCEDURE, 2023 VS. 2028
    • FIGURE 10 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 BREAST BIOPSY DEVICES MARKET SHARE, BY APPLICATION, 2023 VS. 2028
    • FIGURE 12 BREAST BIOPSY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF BREAST BIOPSY DEVICES MARKET

4 PREMIUM INSIGHTS

  • 4.1 BREAST BIOPSY DEVICES MARKET OVERVIEW
    • FIGURE 14 INCREASING PREVALENCE OF BREAST CANCER TO DRIVE MARKET GROWTH
  • 4.2 BREAST BIOPSY DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 ASSAY KITS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 4.3 BREAST BIOPSY DEVICES MARKET, PROCEDURE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 NEEDLE BREAST BIOPSY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.4 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 17 IMAGE-GUIDED BIOPSY TO ACCOUNT FOR LARGEST SHARE OF BREAST BIOPSY DEVICES MARKET IN 2028
  • 4.5 BREAST BIOPSY DEVICES MARKET, APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 18 EARLY CANCER SCREENING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.6 BREAST BIOPSY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 19 BREAST CARE CENTERS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 4.7 BREAST BIOPSY DEVICES MARKET, BY REGION, 2021-2028
    • FIGURE 20 ASIA PACIFIC TO WITNESS HIGHEST GROWTH IN MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 21 BREAST BIOPSY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing incidence of breast cancer
    • FIGURE 22 NUMBER OF BREAST CANCER CASES, BY COUNTRY, 2020
      • 5.2.1.2 Increasing number of breast cancer screening programs
      • 5.2.1.3 Increasing demand for minimally invasive and non-invasive procedures
      • 5.2.1.4 Growing awareness of early detection of breast cancer
      • 5.2.1.5 Improved reimbursement scenario
    • TABLE 2 MEDICARE REIMBURSEMENT FOR BREAST BIOPSY PROCEDURES
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Risk of infections associated with biopsy needles
      • 5.2.2.2 Stringent regulatory approval procedures
      • 5.2.2.3 Product recalls
    • TABLE 3 FDA-INITIATED PRODUCT RECALLS
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth potential in emerging economies
      • 5.2.3.2 Emergence of liquid biopsy and promising clinical trials
    • TABLE 4 LIQUID BIOPSY CLINICAL TRIALS
      • 5.2.3.3 Increasing public-private investments and funding
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled professionals and inadequate healthcare infrastructure
  • 5.3 REGULATORY LANDSCAPE
    • 5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.3.2 REGULATORY ANALYSIS
      • 5.3.2.1 North America
        • 5.3.2.1.1 US
    • TABLE 10 US FDA-APPROVED BIOPSY DEVICES
    • TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 12 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
        • 5.3.2.1.2 Canada
    • TABLE 13 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.3.2.2 Europe
      • 5.3.2.3 Asia Pacific
        • 5.3.2.3.1 Japan
    • TABLE 14 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
        • 5.3.2.3.2 China
    • TABLE 15 CHINA: CLASSIFICATION OF MEDICAL DEVICES
        • 5.3.2.3.3 India
  • 5.4 VALUE CHAIN ANALYSIS
    • 5.4.1 RESEARCH & DEVELOPMENT
    • 5.4.2 PROCUREMENT & PRODUCT DEVELOPMENT
    • 5.4.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES
    • FIGURE 23 VALUE CHAIN ANALYSIS-MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
  • 5.5 SUPPLY CHAIN ANALYSIS
    • 5.5.1 PROMINENT COMPANIES
    • 5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES
    • 5.5.3 END USERS
    • FIGURE 24 BREAST BIOPSY DEVICES MARKET: SUPPLY CHAIN ANALYSIS
  • 5.6 ECOSYSTEM MARKET MAP
    • TABLE 16 BREAST BIOPSY DEVICES MARKET: ROLE IN ECOSYSTEM
  • 5.7 TECHNOLOGY ANALYSIS
  • 5.8 TRADE ANALYSIS
    • TABLE 17 IMPORT DATA FOR BIOPSY NEEDLES (HS CODE 90183240), BY COUNTRY, 2018-2022 (USD THOUSAND)
    • TABLE 18 EXPORT DATA FOR BREAST BIOPSY DEVICES (HS CODE 90183240), BY COUNTRY, 2018-2022 (USD THOUSAND)
    • TABLE 19 IMPORT DATA FOR MAMMOGRAPHY DEVICES (HS CODE 90221411), BY COUNTRY, 2018-2022 (USD THOUSAND)
    • TABLE 20 EXPORT DATA FOR MAMMOGRAPHY DEVICES (HS CODE 90221411), BY COUNTRY, 2018-2022 (USD THOUSAND)
  • 5.9 PATENT ANALYSIS
    • FIGURE 25 PATENT DETAILS FOR BREAST BIOPSY (JANUARY 2012-JULY 2023)
  • 5.10 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 21 BREAST BIOPSY DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.10.1 THREAT OF NEW ENTRANTS
    • 5.10.2 THREAT OF SUBSTITUTES
    • 5.10.3 BARGAINING POWER OF SUPPLIERS
    • 5.10.4 BARGAINING POWER OF BUYERS
    • 5.10.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.11 PRICING ANALYSIS
    • 5.11.1 AVERAGE SELLING PRICE OF PRODUCTS, BY TYPE
    • TABLE 22 AVERAGE SELLING PRICE OF PRODUCTS (USD), 2022
    • 5.11.2 AVERAGE SELLING PRICE TRENDS
  • 5.12 CASE STUDY ANALYSIS
    • 5.12.1 CASE STUDY 1: EVOLUTION OF WIRE LOCALIZATION TECHNIQUE
    • FIGURE 26 BREAST TUMOR LOCALIZATION: TECHNOLOGY EVOLUTION CHART
    • 5.12.2 CASE STUDY 2: GROWING BREAST CARE FACILITIES IN US
  • 5.13 KEY CONFERENCES & EVENTS, 2023-2025
    • TABLE 23 BREAST BIOPSY DEVICES MARKET: LIST OF MAJOR CONFERENCES & EVENTS (2023-2025)
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS & BUYING CRITERIA
    • FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BREAST BIOPSY DEVICES
    • 5.14.2 BUYING CRITERIA
    • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BREAST BIOPSY DEVICES
    • FIGURE 28 KEY BUYING CRITERIA FOR BREAST BIOPSY DEVICES
    • TABLE 25 KEY BUYING CRITERIA FOR BREAST BIOPSY DEVICES

6 BREAST BIOPSY DEVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 26 BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 27 BREAST BIOPSY DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.2 BIOPSY NEEDLES
    • 6.2.1 TECHNOLOGICAL ADVANCEMENTS IN BIOPSY NEEDLES TO DRIVE MARKET GROWTH
    • TABLE 28 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 29 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 30 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 31 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 32 BREAST BIOPSY DEVICES MARKET FOR BIOPSY NEEDLES, BY END USER, 2021-2028 (USD MILLION)
  • 6.3 GUIDANCE SYSTEMS
    • 6.3.1 PROCEDURAL ADVANTAGES OF GUIDED BIOPSIES TO FUEL GROWTH
    • TABLE 33 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 34 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 35 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 36 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 37 BREAST BIOPSY DEVICES MARKET FOR GUIDANCE SYSTEMS, BY END USER, 2021-2028 (USD MILLION)
  • 6.4 BIOPSY TABLES
    • 6.4.1 GROWING USE OF BIOPSY TABLES TO PERFORM STEREOTACTIC BIOPSY PROCEDURES TO FAVOR MARKET GROWTH
    • TABLE 38 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 39 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 40 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 41 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 42 BREAST BIOPSY DEVICES MARKET FOR BIOPSY TABLES, BY END USER, 2021-2028 (USD MILLION)
  • 6.5 ASSAY KITS
    • 6.5.1 PRODUCT APPROVALS AND LAUNCHES TO DRIVE SEGMENTAL GROWTH
    • TABLE 43 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 44 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 45 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 46 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 47 BREAST BIOPSY DEVICES MARKET FOR ASSAY KITS, BY END USER, 2021-2028 (USD MILLION)
  • 6.6 LIQUID BIOPSY INSTRUMENTS
    • 6.6.1 ONGOING RESEARCH AND CLINICAL TRIALS TO DELIVER NOVEL SOLUTIONS IN MARKET
    • TABLE 48 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 49 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 50 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 51 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 52 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY INSTRUMENTS, BY END USER, 2021-2028 (USD MILLION)
  • 6.7 LOCALIZATION WIRES
    • 6.7.1 WIDE USAGE OF LOCALIZATION WIRES TO LOCATE BREAST ABNORMALITIES AND LUMPS TO BOOST MARKET
    • TABLE 53 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 54 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 55 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 56 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 57 BREAST BIOPSY DEVICES MARKET FOR LOCALIZATION WIRES, BY END USER, 2021-2028 (USD MILLION)
  • 6.8 OTHER DEVICES
    • TABLE 58 OTHER BREAST BIOPSY DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 59 OTHER BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 60 OTHER BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 61 OTHER BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 62 OTHER BREAST BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)

7 BREAST BIOPSY DEVICES MARKET, BY PROCEDURE

  • 7.1 INTRODUCTION
    • TABLE 63 BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021-2028 (USD MILLION)
  • 7.2 NEEDLE BREAST BIOPSY
    • TABLE 64 BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • 7.2.1 CORE-NEEDLE BIOPSY
      • 7.2.1.1 Procedural advantages of guidance system-based biopsy to drive revenue growth
    • TABLE 65 BREAST BIOPSY DEVICES MARKET FOR CORE-NEEDLE BIOPSY, BY REGION, 2021-2028 (USD MILLION)
    • 7.2.2 VACUUM-ASSISTED BIOPSY
      • 7.2.2.1 High diagnostic specificity and accuracy of technique to boost demand
    • TABLE 66 BREAST BIOPSY DEVICES MARKET FOR VACUUM-ASSISTED BIOPSY, BY REGION, 2021-2028 (USD MILLION)
    • 7.2.3 FINE-NEEDLE ASPIRATION BIOPSY
      • 7.2.3.1 Drawbacks associated with procedure to limit market growth
    • TABLE 67 BREAST BIOPSY DEVICES MARKET FOR FINE-NEEDLE ASPIRATION BIOPSY, BY REGION, 2021-2028 (USD MILLION)
  • 7.3 OPEN SURGICAL BREAST BIOPSY
    • TABLE 68 BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • 7.3.1 EXCISIONAL BIOPSY
      • 7.3.1.1 Risk of postoperative complications to hinder market growth
    • TABLE 69 BREAST BIOPSY DEVICES MARKET FOR EXCISIONAL BIOPSY, BY REGION, 2021-2028 (USD MILLION)
    • 7.3.2 INCISIONAL BIOPSY
      • 7.3.2.1 Longer recovery period associated with incisional biopsy to restrict growth
    • TABLE 70 BREAST BIOPSY DEVICES MARKET FOR INCISIONAL BIOPSY, BY REGION, 2021-2028 (USD MILLION)
  • 7.4 LIQUID BREAST BIOPSY
    • TABLE 71 BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • 7.4.1 CIRCULATING TUMOR CELLS
      • 7.4.1.1 Ability to provide important information on molecular properties of breast tumors to boost market
    • TABLE 72 BREAST BIOPSY DEVICES MARKET FOR CIRCULATING TUMOR CELLS, BY REGION, 2021-2028 (USD MILLION)
    • 7.4.2 CIRCULATING TUMOR DNA
      • 7.4.2.1 Low concentrations of ctDNA to pose challenges in screening mutations
    • TABLE 73 BREAST BIOPSY DEVICES MARKET FOR CIRCULATING TUMOR DNA, BY REGION, 2021-2028 (USD MILLION)
    • 7.4.3 OTHER BIOMARKERS
    • TABLE 74 BREAST BIOPSY DEVICES MARKET FOR OTHER BIOMARKERS, BY REGION, 2021-2028 (USD MILLION)

8 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE

  • 8.1 INTRODUCTION
    • TABLE 75 BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
  • 8.2 IMAGE-GUIDED BIOPSY
    • TABLE 76 BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • 8.2.1 MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY
      • 8.2.1.1 Increasing number of government-initiated breast screening programs to drive segmental growth
    • TABLE 77 BREAST BIOPSY DEVICES MARKET FOR MAMMOGRAPHY-GUIDED STEREOTACTIC BIOPSY, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.2 ULTRASOUND-GUIDED BIOPSY
      • 8.2.2.1 Advantages of technique to boost adoption in coming years
    • TABLE 78 BREAST BIOPSY DEVICES MARKET FOR ULTRASOUND-GUIDED BIOPSY, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.3 MRI-GUIDED BIOPSY
      • 8.2.3.1 High cost and low specificity to affect demand
    • TABLE 79 BREAST BIOPSY DEVICES MARKET FOR MRI-GUIDED BIOPSY, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 LIQUID BIOPSY
    • TABLE 80 BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • 8.3.1 PCR-BASED BIOPSY
      • 8.3.1.1 Continuous advancements in PCR technology to propel growth
    • TABLE 81 BREAST BIOPSY DEVICES MARKET FOR PCR-BASED BIOPSY, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.2 NGS-BASED BIOPSY
      • 8.3.2.1 Technological advancements and advantages to drive growth
    • TABLE 82 NGS-BASED TECHNOLOGIES FOR ONCOLOGY APPLICATIONS
    • TABLE 83 BREAST BIOPSY DEVICES MARKET FOR NGS-BASED BIOPSY, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.3 MICROARRAY-BASED BIOPSY
      • 8.3.3.1 Ongoing research and promising results to drive market growth
    • TABLE 84 BREAST BIOPSY DEVICES MARKET FOR MICROARRAY-BASED BIOPSY, BY REGION, 2021-2028 (USD MILLION)
  • 8.4 OTHER TECHNIQUES
    • TABLE 85 BREAST BIOPSY DEVICES MARKET FOR OTHER TECHNIQUES, BY REGION, 2021-2028 (USD MILLION)

9 BREAST BIOPSY DEVICES MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 86 BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 9.2 EARLY CANCER SCREENING
    • 9.2.1 GROWING AWARENESS ABOUT EARLY CANCER DETECTION TO DRIVE MARKET GROWTH
    • TABLE 87 BREAST BIOPSY DEVICES MARKET FOR EARLY CANCER SCREENING, BY REGION, 2021-2028 (USD MILLION)
  • 9.3 THERAPY SELECTION
    • 9.3.1 EMERGENCE OF PLASMA-BASED GENOTYPING TO DRIVE GROWTH IN DEVELOPED COUNTRIES
    • TABLE 88 BREAST BIOPSY DEVICES MARKET FOR THERAPY SELECTION, BY REGION, 2021-2028 (USD MILLION)
  • 9.4 TREATMENT MONITORING
    • 9.4.1 GROWING DEMAND FOR LIQUID BIOPSY FOR REAL-TIME TREATMENT MONITORING TO BOOST MARKET
    • TABLE 89 BREAST BIOPSY DEVICES MARKET FOR TREATMENT MONITORING, BY REGION, 2021-2028 (USD MILLION)
  • 9.5 RECURRENCE MONITORING
    • 9.5.1 UNMET CLINICAL NEEDS TO CREATE OPPORTUNITIES FOR PLAYERS
    • TABLE 90 BREAST BIOPSY DEVICES MARKET FOR RECURRENCE MONITORING, BY REGION, 2021-2028 (USD MILLION)

10 BREAST BIOPSY DEVICES MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 91 BREAST BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.2 HOSPITALS & SURGICAL CENTERS
    • 10.2.1 RISING DEMAND FOR QUICK AND ACCURATE DIAGNOSIS TO BOOST MARKET
    • TABLE 92 BREAST BIOPSY DEVICES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • 10.3 BREAST CARE CENTERS
    • 10.3.1 GROWING POPULARITY OF BREAST CARE CENTERS IN DEVELOPED COUNTRIES TO FUEL GROWTH
    • TABLE 93 BREAST BIOPSY DEVICES MARKET FOR BREAST CARE CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • 10.4 IMAGING CLINICS & DIAGNOSTIC CENTERS
    • 10.4.1 RISING NUMBER OF PRIVATE IMAGING CENTERS TO CONTRIBUTE TO MARKET GROWTH
    • TABLE 94 BREAST BIOPSY DEVICES MARKET FOR IMAGING CLINICS & DIAGNOSTIC CENTERS, BY REGION, 2021-2028 (USD MILLION)

11 BREAST BIOPSY DEVICES MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 95 BREAST BIOPSY DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 11.2 NORTH AMERICA
    • FIGURE 29 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET SNAPSHOT
    • 11.2.1 NORTH AMERICA: RECESSION IMPACT
    • TABLE 96 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 97 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 98 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021-2028 (USD MILLION)
    • TABLE 99 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 100 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 101 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 102 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 103 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 104 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 105 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 106 NORTH AMERICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.2.2 US
      • 11.2.2.1 US to dominate North American breast biopsy devices market during forecast period
    • TABLE 107 US: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.2.3 CANADA
      • 11.2.3.1 Growing incidence of breast cancer and favorable government guidelines to support market growth
    • TABLE 108 CANADA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 11.3 EUROPE
    • 11.3.1 EUROPE: RECESSION IMPACT
    • TABLE 109 EUROPE: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 110 EUROPE: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 111 EUROPE: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021-2028 (USD MILLION)
    • TABLE 112 EUROPE: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 113 EUROPE: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 114 EUROPE: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 115 EUROPE: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 116 EUROPE: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 117 EUROPE: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 118 EUROPE: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 EUROPE: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.2 GERMANY
      • 11.3.2.1 Favorable changes in reimbursement scenario to fuel adoption of technologically advanced products
    • TABLE 120 GERMANY: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.3.3 UK
      • 11.3.3.1 Initiatives by public & private organizations to increase awareness about breast cancer
    • TABLE 121 UK: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.3.4 FRANCE
      • 11.3.4.1 Rising geriatric population to support market growth
    • TABLE 122 FRANCE: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.3.5 ITALY
      • 11.3.5.1 Evolving regulatory scenario for breast biopsy to boost market
    • TABLE 123 ITALY: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.3.6 SPAIN
      • 11.3.6.1 Government focus on early and effective breast cancer diagnosis to favor market growth
    • TABLE 124 SPAIN: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.3.7 REST OF EUROPE
    • TABLE 125 REST OF EUROPE: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • FIGURE 30 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET SNAPSHOT
    • 11.4.1 ASIA PACIFIC: RECESSION IMPACT
    • TABLE 126 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 127 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 128 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021-2028 (USD MILLION)
    • TABLE 129 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 130 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 131 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 132 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 133 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 134 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 135 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 136 ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.2 CHINA
      • 11.4.2.1 Increasing patient pool and government initiatives for healthcare development to fuel market growth
    • TABLE 137 CHINA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.4.3 JAPAN
      • 11.4.3.1 Presence of universal healthcare reimbursement scenario to support growth
    • TABLE 138 JAPAN: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.4.4 INDIA
      • 11.4.4.1 Government initiatives to improve female health to drive market growth in India
    • TABLE 139 INDIA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.4.5 AUSTRALIA
      • 11.4.5.1 Rising research investments and awareness campaigns to fuel growth
    • TABLE 140 AUSTRALIA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.4.6 SOUTH KOREA
      • 11.4.6.1 Rising R&D and promising clinical trials to positively impact market growth
    • TABLE 141 SOUTH KOREA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.4.7 REST OF ASIA PACIFIC
    • TABLE 142 REST OF ASIA PACIFIC: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 11.5 LATIN AMERICA
    • 11.5.1 LATIN AMERICA: RECESSION IMPACT
    • TABLE 143 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 144 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 145 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021-2028 (USD MILLION)
    • TABLE 146 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 147 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 148 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 149 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 150 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 151 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 152 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 153 LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.5.2 BRAZIL
      • 11.5.2.1 Brazil to dominate Latin American market during forecast period
    • TABLE 154 BRAZIL: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.5.3 MEXICO
      • 11.5.3.1 Availability of advanced care and increasing awareness programs to fuel market growth
    • TABLE 155 MEXICO: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.5.4 REST OF LATIN AMERICA
    • TABLE 156 REST OF LATIN AMERICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 11.5.5 MIDDLE EAST & AFRICA
      • 11.5.5.1 Improving healthcare infrastructure and increasing public-private investments to drive market
    • 11.5.6 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • TABLE 157 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 158 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY PROCEDURE, 2021-2028 (USD MILLION)
    • TABLE 159 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR NEEDLE BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 160 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR OPEN SURGICAL BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 161 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BREAST BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 162 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 163 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY TECHNIQUE, 2021-2028 (USD MILLION)
    • TABLE 164 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR IMAGE-GUIDED BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 165 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET FOR LIQUID BIOPSY, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 166 MIDDLE EAST & AFRICA: BREAST BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
    • FIGURE 31 KEY DEVELOPMENTS BY LEADING PLAYERS IN BREAST BIOPSY DEVICES MARKET, JANUARY 2020-FEBRUARY 2022
  • 12.2 STRATEGIES ADOPTED BY KEY PLAYERS
  • 12.3 REVENUE SHARE ANALYSIS
    • FIGURE 32 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS
  • 12.4 MARKET SHARE ANALYSIS
    • FIGURE 33 BREAST BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER (2022)
  • 12.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • FIGURE 34 BREAST BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX (2022)
  • 12.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • FIGURE 35 BREAST BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
  • 12.7 COMPETITIVE BENCHMARKING
    • TABLE 167 BREAST BIOPSY DEVICES MARKET: COMPETITIVE BENCHMARKING
  • 12.8 COMPANY FOOTPRINT ANALYSIS
    • TABLE 168 BREAST BIOPSY DEVICES MARKET: REGIONAL FOOTPRINT ANALYSIS
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT LAUNCHES & APPROVALS
    • 12.9.2 DEALS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 13.1.1 HOLOGIC, INC.
    • TABLE 169 HOLOGIC, INC.: BUSINESS OVERVIEW
    • FIGURE 36 HOLOGIC, INC.: COMPANY SNAPSHOT (2022)
    • TABLE 170 HOLOGIC, INC.: PRODUCT LAUNCHES & APPROVALS
    • TABLE 171 HOLOGIC, INC.: DEALS
    • 13.1.2 DANAHER CORPORATION
    • TABLE 172 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 173 DANAHER CORPORATION: PRODUCT LAUNCHES
    • 13.1.3 BECTON, DICKINSON AND COMPANY
    • TABLE 174 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
    • TABLE 175 BECTON, DICKINSON AND COMPANY: EXPANSIONS
    • 13.1.4 QIAGEN
    • TABLE 176 QIAGEN: BUSINESS OVERVIEW
    • FIGURE 39 QIAGEN: COMPANY SNAPSHOT (2022)
    • TABLE 177 QIAGEN: PRODUCT LAUNCHES
    • 13.1.5 F. HOFFMANN-LA ROCHE LTD.
    • TABLE 178 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
    • FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
    • 13.1.6 ARGON MEDICAL DEVICES
    • TABLE 179 ARGON MEDICAL DEVICES: BUSINESS OVERVIEW
    • TABLE 180 ARGON MEDICAL DEVICES: PRODUCT LAUNCHES
    • TABLE 181 ARGON MEDICAL DEVICES: DEALS
    • 13.1.7 MERIT MEDICAL SYSTEMS
    • TABLE 182 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW
    • FIGURE 41 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2022)
    • TABLE 183 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS
    • TABLE 184 MERIT MEDICAL SYSTEMS: DEALS
    • 13.1.8 MENARINI SILICON BIOSYSTEMS SPA
    • TABLE 185 MENARINI SILICON BIOSYSTEMS: BUSINESS OVERVIEW
    • TABLE 186 MENARINI SILICON BIOSYSTEMS: PRODUCT LAUNCHES
    • TABLE 187 MENARINI SILICON BIOSYSTEMS: DEALS
    • 13.1.9 GUARDANT HEALTH, INC.
    • TABLE 188 GUARDANT HEALTH, INC.: BUSINESS OVERVIEW
    • FIGURE 42 GUARDANT HEALTH, INC.: COMPANY SNAPSHOT (2022)
    • TABLE 189 GUARDANT HEALTH, INC.: DEALS
    • 13.1.10 NEOGENOMICS LABORATORIES, INC.
    • TABLE 190 NEOGENOMICS LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 43 NEOGENOMICS LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
    • TABLE 191 NEOGENOMICS LABORATORIES, INC.: PRODUCT LAUNCHES
    • TABLE 192 NEOGENOMICS LABORATORIES, INC.: DEALS
    • 13.1.11 STERYLAB S.R.L
    • TABLE 193 STERYLAB S.R.L: BUSINESS OVERVIEW
    • 13.1.12 BIOCEPT, INC.
    • TABLE 194 BIOCEPT, INC.: BUSINESS OVERVIEW
    • 13.1.13 BIO-RAD LABORATORIES, INC.
    • TABLE 195 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
    • 13.1.14 EXACT SCIENCES CORPORATION
    • TABLE 196 EXACT SCIENCES CORPORATION: BUSINESS OVERVIEW
    • FIGURE 45 EXACT SCIENCES CORPORATION: COMPANY SNAPSHOT (2022)
    • TABLE 197 EXACT SCIENCES CORPORATION: DEALS
    • 13.1.15 SYSMEX INOSTICS, INC. (A SUBSIDIARY OF SYSMEX CORPORATION)
    • TABLE 198 SYSMEX INOSTICS: BUSINESS OVERVIEW
    • FIGURE 46 SYSMEX INOSTICS: COMPANY SNAPSHOT (2022)
    • TABLE 199 SYSMEX INOSTICS: DEALS
  • 13.2 OTHER PLAYERS
    • 13.2.1 THERMO FISHER SCIENTIFIC
    • 13.2.2 CARDIFF ONCOLOGY INC.
    • 13.2.3 MYRIAD GENETICS, INC.
    • 13.2.4 ILLUMINA, INC.
    • 13.2.5 FLUXION BIOSCIENCES, INC.
    • 13.2.6 FUJIFILM HOLDINGS CORPORATION
    • 13.2.7 INRAD, INC.
    • 13.2.8 IZI MEDICAL PRODUCTS
    • 13.2.9 REMINGTON MEDICAL INC.
    • 13.2.10 CP MEDICAL
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS